2022 annual financial data
Kura Oncology 2022 Operating margin
Direct answer
Operating margin was Not calculable.
Operating income was -139,865,000 USD and net income was -135,840,000 USD.
Operating cash flow was -110,062,000 USD.
Get free Kura Oncology email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -139,865,000 USD
- Net income
- -135,840,000 USD
- Operating cash flow
- -110,062,000 USD